eBook: Why is antibody development so important?

Would knowing how the leaders in the field of antibodies think therapeutic development will continue over the next 5 years be of benefit to you?  Would knowing what they want to discuss, and where they plan on having these discussions be useful information to your business?  Whether you are looking to maintain, develop or enter the exciting field of antibody …

GeneTherapy: 2nd generation therapies from AMT, INSERM and ArkTherapeutics

AMT, INSERM and Ark Therapeutics shared goal of achieving an approved gene therapy has led them all to explore what are becoming known as the 2nd generation therapies, and they will be discussing these ideas at the World Gene Therapy Congress in London later this year. Prof Alain Fischer from INSERM will be delivering his recent results in his work …